Editas Medicine (EDIT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's ...

HG302’s developers have moved on to testing the treatment in humans as part of a multidose, dose-escalation study to understand the safety of CRISPR gene-editing therapy and its long-lasting ...

Two Democrat-run cities in the Rockies are skirting state laws dictating which flags can be flown on government property, according to The Associated Press – and are granting particular ...

Google is upgrading the Gemini app with a powerful AI Image Editing tool that lets users bring their creative imagination to life. The new feature will enable you to edit both AI-generated images ...

And why I bought one for smartphone videography That’s the theory, anyway. In reality, editing 360 footage has always been a painful, frustrating slog, at least in my personal experience.

Archaeologists discovered a Celtic necropolis from the second Iron Age filled with metal artifacts. The team located two swords still in their sheaths covered in ornate decorations. The swastika ...

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene ...

A baby in the US is among the first people with a rare genetic disorder to be treated with CRISPR, a customised gene-editing therapy that allows scientists to edit DNA. The baby, known as KJ ...

Form error message goes here. Thank you. Please check your inbox to confirm.

To Ukrainian authorities, it is a threat that must be eliminated under a so-called decolonization law ordering the removal of “symbols of Russian imperial politics” to protect Ukrainian culture.

DeFi Development Corp. announced that it will start trading under the new ticker symbol "DFDV" on the Nasdaq Capital Market, effective May 5, 2025, following its recent corporate name change and ...